BioVenture
Asia, Jiangsu, China, Suzhou'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
BioVenture is a Chinese venture capital firm that offers early and growth stage investment services.
Investor Profile
BioVenture has made 22 investments, with 7 in the past 12 months and 32% as lead.
Stage Focus
- Series A (36%)
- Series B (32%)
- Series Unknown (18%)
- Seed (9%)
- Series C (5%)
Country Focus
- China (68%)
- United States (18%)
- Hong Kong (5%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
- Germany (5%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Medical Device
- Pharmaceutical
- Health Diagnostics
- Manufacturing
- Biopharma
- Oncology
- Mobile
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
